Mechanism of extrasynaptic dopamine signaling in Caenorhabditis elegans

Nature Neuroscience
Daniel L ChaseMichael R Koelle

Abstract

D1-like and D2-like dopamine receptors have synergistic and antagonistic effects on behavior. To understand the mechanisms underlying these effects, we studied dopamine signaling genetically in Caenorhabditis elegans. Knocking out a D2-like receptor, DOP-3, caused locomotion defects similar to those observed in animals lacking dopamine. Knocking out a D1-like receptor, DOP-1, reversed the defects of the DOP-3 knockout. DOP-3 and DOP-1 have their antagonistic effects on locomotion by acting in the same motor neurons, which coexpress the receptors and which are not postsynaptic to dopaminergic neurons. In a screen for mutants unable to respond to dopamine, we identified four genes that encode components of the antagonistic Galpha(o) and Galpha(q) signaling pathways, including Galpha(o) itself and two subunits of the regulator of G protein signaling (RGS) complex that inhibits Galpha(q). Our results indicate that extrasynaptic dopamine regulates C. elegans locomotion through D1- and D2-like receptors that activate the antagonistic Galpha(q) and Galpha(o) signaling pathways, respectively.

References

Jan 1, 1997·Brain Research Bulletin·Y IkarashiY Maruyama
Jan 1, 1997·Journal of Psychopharmacology·M B Knable, D R Weinberger
Feb 11, 1998·Physiological Reviews·C MissaleM G Caron
Oct 8, 1998·The New England Journal of Medicine·A E Lang, A M Lozano
Oct 13, 1998·Neuron·G F KoobF E Bloom
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·M JiangL Birnbaumer
May 2, 2001·Parkinsonism & Related Disorders·R F. Wintle, H H.M. Van Tol
Jan 30, 2002·Neuroscience Letters·Satoshi SuoShoichi Ishiura
Feb 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Richard NassRandy D Blakely
Jun 13, 2002·Proceedings of the National Academy of Sciences of the United States of America·Robert E CampbellRoger Y Tsien
Nov 5, 2002·Annual Review of Pharmacology and Toxicology·Richard Nass, Randy D Blakely
Dec 24, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Fergal N McNamaraJohn L Waddington
Jul 31, 2003·Journal of Neurochemistry·Satoshi SuoShoichi Ishiura
Jan 24, 2004·The EMBO Journal·Suparna SanyalHubert H M Van Tol
Nov 12, 1986·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·J G WhiteS Brenner

❮ Previous
Next ❯

Citations

Aug 10, 2006·Cell and Tissue Research·Mark SeifertRalf Baumeister
Nov 21, 2007·Invertebrate Neuroscience : in·Katherine A SmithJohn Gray
May 26, 2006·Cellular and Molecular Neurobiology·Paul W McDonaldRandy D Blakely
Aug 2, 2011·Chemical Reviews·Yulia V ShulgaRichard M Epand
May 31, 2012·Behavioral Neuroscience·Heather N MusselmanEric A Engleman
Sep 29, 2004·Nature Neuroscience·Erik M Jorgensen
Oct 5, 2011·Proceedings of the National Academy of Sciences of the United States of America·Andrés Vidal-GadeaJonathan T Pierce-Shimomura
Jan 19, 2013·Animal Cells and Systems·Young-Jai You, Leon Avery
Apr 23, 2010·Molecular Pharmacology·Lucia CarvelliAurelio Galli
Jul 19, 2005·Annual Review of Neuroscience·Mario de Bono, Andres Villu Maricq
Mar 23, 2005·BMC Genomics·Rebecca M FoxDavid M Miller
Dec 3, 2008·Disease Models & Mechanisms·Guy A Caldwell, Kim A Caldwell
Apr 9, 2013·PLoS Biology·Jamie L DonnellyMark J Alkema
Jun 19, 2009·PloS One·Alex WardX Z Shawn Xu
Nov 26, 2010·PloS One·Greg J StephensWilliam S Ryu
Jan 27, 2011·PloS One·Irina SinakevitchBrian H Smith
Jun 22, 2012·PloS One·Daniel T OmuraH Robert Horvitz
Jan 28, 2014·PloS One·Alexandre Guimarães de Almeida BarrosMarco Aurélio Romano-Silva
Jul 11, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jeremy S Dittman, Joshua M Kaplan
Aug 30, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jason P ChanDerek Sieburth
Oct 22, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Belinda BarbagalloMichael M Francis
Jun 6, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Marta Maria Gaglia, Cynthia Kenyon
Jan 25, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jessica C Nelson, Daniel A Colón-Ramos
Mar 22, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yingchuan B QiYishi Jin
Dec 1, 2007·WormBook : the Online Review of C. Elegans Biology·Miriam B Goodman
Jun 3, 2011·Journal of Visualized Experiments : JoVE·Chi K LeungKeith P Choe
Apr 1, 2014·PloS One·Stephen M TopperJonathan T Pierce-Shimomura
Jan 19, 2006·Proceedings of the National Academy of Sciences of the United States of America·Masahiro MatsukiYuichi Iino

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.